Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Small Cell Lung Cancer
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

To determine the optimal schedule for three-dimensional verification imaging and necessary re-planning of patients undergoing IMPT for a rapidly changing tumor (small cell lung cancer). To determine the rate of cardiac toxicities from IMPT in patients with small cell lung cancer compared with histor...

To determine the optimal schedule for three-dimensional verification imaging and necessary re-planning of patients undergoing IMPT for a rapidly changing tumor (small cell lung cancer). To determine the rate of cardiac toxicities from IMPT in patients with small cell lung cancer compared with historical controls receiving photon-based treatment. To determine the rate of pneumonitis and esophagitis from IMPT and compare with historical controls receiving photon based treatment.

Tracking Information

NCT #
NCT04342429
Collaborators
Not Provided
Investigators
Principal Investigator: Kristin Higgins, MD Emory University-Winship Cancer Institute